Prognostic value of the monoethylglycinexylidide test in alcoholic cirrhosis

Saudi Journal of Gastroenterology

Volumn 13, Issue 3, 2007, Pages 118-123

  Bhise, Satish B ^a   Dias, Remeth J ^b   Mali, Kailas K ^a  

^a Govt College of Pharmacy   (India)

^b Behind Spicer India Ltd   (India)

Author keywords

Alcoholic cirrhosis; Monoethylglycinexylidide

Indexed keywords

EID: 34547486501     PISSN: 13193767     EISSN: None     Source Type: Journal    
DOI: 10.4103/1319-3767.33462     Document Type: Article

References (25)

1. Cirrhosis of the liver, [database on the Internet], Bethesda (MD): National Digestive Diseases Information Clearing House. NIH Publication No. 04-1134. Dec 2003 [cited 2005 Dec]. Available from: http://digestive. niddk.nih.gov/ddiseases/pubs/cirrhosis.
2. Botta I; Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: AEuropean study. Gut 2003:52:134-9.
3. Durand F, Villa D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005;42:S100-7.
4. Chrislensen E Prognostic models including the Child-Pugh, MELD and Mayo risk scorcs-where are we and where should we go? J Hepatol 2004;41:344-50.
5. Iernaandcz-Esparrach G, Saanchez-Rteyo A, Cuneas P, Uriz J, Quintoa L, Ventura P, et al. A prognostic model for predicting survival in cirrhosis with ascites. JHepatol 2001;34:46-52.
6. Gunsar F, Raimondo MI, Jones S. Terreni N, Wong C, Patch D, et al. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006;24:563-72.
7. Papatheodoridis GV, Cholongitas E, Dimitriadou E, Tbuloumi G, Sevastianos V, Archimandritis AJ. MRID vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005;11:3099-104.
8. Tanaka E, Breimer DD. In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease. J Clin Pharm Ther 1997;22:237-49.
9. Herold C Heinz R Niedobitek G, Schneider T, Halm EG, Schuppan D. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and G Liver 2001:21:260-5.
10. Arrigoni A Gindro T, Amo G, Capello N, Meloni A Benedetti R et al. Monoethylglycincxylidide test: A prognostic indicator of survival in cirrhosis. Hepatology 1994;20:383-7.
11. Oellerich M, Armstrong VW. The megx test: A tool for the real- time assessment of hepatic function. Ther Drug Monit 2001;23:81-92.
12. Corpataux JM, Munafo A Buclin T Biollaz J, Mosimann E Apreliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaine. Hans Proc 2001;33:2557-62.
13. Potter JM Oellerich M. The use of lidocaine as a test of liver function in liver transplantation, liver Transpl Surg 1996;2:211-24.
14. Fabbris L Jemmolo RM, Toffolo G, Paleari D, Maggi S, Rigon M et al. The monoethylglycinexylidide test for grading of liver cirrhosis. Aliment Pharmacol Ther 1999;13:67-75.
15. Kamath PS, Wiesner RlL Malinchoc M Kremers W Thcrneau TM Kosberg CL et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
16. Said A Williams J, Holden J, Remington P, Gangnon R. Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004:40:897-903.
17. Sumskiene J, Kupeinskas I, Pundzius J, Sumskas L Prognostic factors for short and long-term survival in patients selected for liver transplantation. Medicina (Kaunas) 2005;41:39-46.
18. Srikureja W, Kyulo NL Runyon BA Hu K MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis. J Hepatol 2005;42:700-6.
19. Chen Y, Potter J, Ravenscrofl P. High-performance liquid chromatographic method for the simultaneous determination of monoethylglycinexylidide and lignocaine. J Chromatogr 1992;574:361-4.
20. Kim WR, Wiesner RH, Poterucha JJ, Tnerneau TM, Benson JT, Krom RA et al. Adaptation of the mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 2000;6:489-94.
21. Chatzicostas C, Roussomoustakaki M Notas G, Vlachonikolis IG, Samonakis D, Romanos J, et al. A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosis. BMC Gastroenterol 2003;3:7-14.
22. Wiesner RH, McDiarmid SY Kamath PS, Edwards EB, Malinchoc M Kremers WK, et al. MEID and PEID: Application of survival models to liver allocation. Liver Transpl 2001;7:567-80.
23. Shiftman ML Fisher RA Sanyal AJ, Edinboro LE, Luketic VA Purduin PR ef al. Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantation. Transplantation 1993;55:830-4.
24. Leclercq I, Saliez A Wallemacq FE, Horsmans X Iambotte L The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat. Hepatology 1997;26:1182-8.
25. Hin RJ, Fried MW Sampson M Ruddel M Kleiner DE, Dibisceglie AM Assessment of monoethylglycinexylidide as major of liver function for patients with chronic viral hepatitis. Clin Chem 1997;43:1952-7.